Advertisement
In a review article published online Sept. 3 in the New England Journal of Medicine

Suggested Response Provided for In-Flight Medical Emergencies

0
Article offers tips for physicians providing emergency in-flight medical care
Irreversible electroporation in pancreatic cancer cells may improve survival rates for some patients

Irreversible Electroporation Promising in Pancreatic Cancer

0
Study found procedure improved survival for people with stage III disease
A minority of colorectal cancer survivors experience social distress

Social Distress ID’d in Minority of Colorectal Cancer Survivors

0
Strongest predictor of social distress is having three or more long-term conditions
Imetelstat

Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia

0
Responses for patients with myelofibrosis, essential thrombocythemia
There has been an increase in the number of American men with cancer in one breast who have surgery to remove their cancer-free breast

More Male Breast CA Patients Having Both Breasts Removed

0
Trend mirrors the one seen in women, researchers say
An experimental therapy for chronic lymphocytic leukemia that uses a patient's own T cells (an approach known as CTL019) may cure some patients and prolong survival in others

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

0
T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.

Addition of Glitazone to Chemo May Help Treat CML

0
Combining glitazones with standard treatment improved survival in small study
Vietnam veterans exposed to Agent Orange have a more than doubled risk of developing monoclonal gammopathy of undetermined significance

Agent Orange Tied to MGUS in Vietnam Vets

0
Exposed veterans have higher rates of monoclonal gammopathy of undetermined significance
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

0
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
Older patients with acute myeloid leukemia are intense users of health care services and rarely use palliative care and hospice services

Older Cancer Patients Heavily Use Health Care Services

0
Regardless of chemo intensity, palliative care, hospice rarely used with acute myeloid leukemia